Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality , Clinical Phase , Method, Delivery Mode , Indication, End User , and Region: Trend Forecast and Growth OpportunityGlobal pharmacovigilance and drug safety software market will reach $432.3 million by 2031, growing by 7.3% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 82 tables and 92 figures, this 173-page report “Global Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmacovigilance and drug safety...Read more | USD 3,480.00 |
North America Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality , Clinical Phase , Method, Delivery Mode , Indication, End User , and Country: Trend Forecast and Growth OpportunityNorth America pharmacovigilance and drug safety software market is projected to grow by 6.7% annually in the forecast period and reach $158.6 million by 2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 23 tables and 56 figures, this 111-page report “North America Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North...Read more | USD 2,880.00 |
Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality , Clinical Phase , Method, Delivery Mode , Indication, End User , and Country: Trend Forecast and Growth OpportunityEurope pharmacovigilance and drug safety software market was valued at $61.1 million in 2021 and will grow by 7.4% annually over 2021-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 33 tables and 60 figures, this 119-page report “Europe Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Europe pharmacovigilance and drug...Read more | USD 2,880.00 |
Asia Pacific Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality , Clinical Phase , Method, Delivery Mode , Indication, End User , and Country: Trend Forecast and Growth OpportunityAsia Pacific pharmacovigilance and drug safety software market will grow by 8.9% annually with a total addressable market cap of $817.5 million over 2022-2031, driven by the increasing prevalence of chronic diseases due to the aging population, the growing drug discovery pipelines, increase in incidence of adverse drug reactions (ADR), more stringent regulatory guidelines for drug safety, and the increasing adoption of AI and cloud technologies in PV software and solutions. Highlighted with 30 tables and 59 figures, this 117-page report “Asia Pacific Pharmacovigilance and Drug Safety Software Market 2021-2031 by Functionality (Adverse Event Reporting, Drug Safety Audits, Issue Tracking, Fully Integrated), Clinical Phase (Pre-clinical, Phase I-IV), Method, Delivery Mode (On-premise, On-demand), Indication, End User (Pharma and Biotech Companies, CROs, BPOs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia...Read more | USD 2,880.00 |
North America Email Security Market 2021-2031 by Component , Encryption Type , Email Type , Deployment , Industry Vertical, Business Segment , Distribution Channel , and Country: Trend Forecast and Growth OpportunityNorth America email security market is projected to grow by 17.6% annually in the forecast period and reach $ 10,088.1 million by 2031, driven by the increasing data security concerns due to the growing number of email users, the rise in business email compromise (BEC) scams and spear phishing, a high demand for cloud-based email encryption services, and a mandate to comply with privacy regulations and data protection directives. Highlighted with 25 tables and 57 figures, this 110-page report “North America Email Security Market 2021-2031 by Component (Solutions, Services), Encryption Type (Boundary, Gateway-to-Gateway, End-to-End, Hybrid, Client Plugins), Email Type (Web, Mobile), Deployment (Cloud-based, On-premise), Industry Vertical, Business Segment (Large Enterprises, Mid-size Enterprises, Small-size Enterprises, Personal and Home), Distribution Channel (Direct Sales, Distributors and Resellers), and Country: Trend Forecast and Growth Opportunity” is based on a...Read more | USD 2,980.00 |